Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic ...

COPD mortality in China decreased from 2014 to 2021, but the disease burden remains high in underdeveloped regions. COPD is mainly caused by air pollution and smoking, with older adults being the most ...

Chronic obstructive pulmonary disease (COPD) is straining Europe’s healthcare budgets, primarily through preventable ...

Dr MeiLan Han, of the University of Michigan, Ann Arbor, highlights studies in chronic obstructive pulmonary disease (COPD) presented at the CHEST 2021 Annual Meeting. Dr Han first reports on a study ...

Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...

LONDON and RALEIGH, N.C., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces ...

Living Well with COPD provides free one-on-one COPD support, education and resources tailored for every stage of the disease. The program is created for all West Virginians affected by COPD, and their ...

COPD is the name for a group of lung conditions that cause breathing difficulties, which stands for Chronic Obstructive ...

Chronic obstructive pulmonary disease (COPD) is a group of respiratory conditions that include emphysema and chronic bronchitis. It can cause symptoms such as: shortness of breath frequent respiratory ...